DENTSPLY SIRONA (XRAY) cuts 2026 guidance and shares fall
FROM THE WIRE · FINANCE.YAHOO.COM
DENTSPLY SIRONA (XRAY) has drawn fresh attention after cutting its 2026 outlook to about US$3.5b in net sales, pairing the guidance revision with softer third quarter results and comments on regional pressures. The share price reaction has been sharp, with XRAY down 6.24% on the…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA guidance cut from a mid-cap dental company can weigh on the stock and the sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01DENTSPLY SIRONA cut its 2026 outlook to about US$3.5b in net sales.
- 02The revision came with softer third quarter results and comments on regional pressures.
- 03XRAY fell 6.24% on the day of the guidance reset and 18.87% over 90 days.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
DENTSPLY SIRONA Inc.9.46 USDMarket closedtoday -6.24%Negative DENTSPLY INTL7.76 EURMarket closedtoday -13.88%Negative DENTSPLY INTL8.49 EURMarket closedtoday -5.95%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets